Postoperative prostate-specific antigen as a prognostic indicator in patients with margin-positive prostate cancer, undergoing adjuvant radiotherapy after radical prostatectomy

To identify a population of patients within the group with positive surgical margins after radical prostatectomy who would benefit in terms of improved local control of disease by the administration of adju- vant radiation therapy to the prostate bed. Postoperative prostate-specific antigen (PSA) va...

Ausführliche Beschreibung